Phase 1b Study of AEVI-007 in Subjects With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
CPD-DARA in Patients With Relapsed/Refractory Multiple Myeloma.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence
- Status
- RECRUITING
- Phase
- NA
CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma
- Status
- SUSPENDED
- Phase
- PHASE2
A Study to Investigate the Relationship Between Duration of Treatment and Response in Patients With Multiple Myeloma (MM) or Systemic AL Amyloidosis Treated in Real-life Practice
- Status
- COMPLETED
- Phase
- N/A
CORONADO (Circulating tumOur pROtein quaNtification cApillary blooD cOvid-19)
- Status
- UNKNOWN
- Phase
- N/A
Daratumumab for First Line Treatment of Transplant-ineligible Myeloma Patients Followed by Daratumumab Re-treatment at First Relapse
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone in NDMM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Study of T Cell Infusion Targeting BCMA Chimeric Antigen Receptor
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
National Longitudinal Cohort of Hematological Diseases
- Status
- RECRUITING
- Phase
- N/A
Anti-BCMA CAR-T Cell Therapy for the R/R Multiple Myeloma
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Steroid Sparing Treatment With in Newly Diagnosed Transplant Ineligible Patients With Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE1
Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT
- Status
- COMPLETED
- Phase
- NA
Observational Study of Home Administration of Carfilzomib
- Status
- WITHDRAWN
- Phase
- N/A
BCMA and CD19 Targeted Fast Dual CART for Chromosomal Abnomalities High-risk BCMA+ Multiple Myeloma
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
FT538 in Subjects With Advanced Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Vertebral Fat Quantitative MRI as a Marker of Bone Fragility in Multiple Myeloma (MYELOMEFRAGIQUANTI)
- Status
- UNKNOWN
- Phase
- N/A